Related Experiment Video
Updated: Jun 28, 2025

08:32
Culturing and Manipulation of O9-1 Neural Crest Cells
Published on: October 9, 2018
10.1K
Decoding the Impact of the Hippo Pathway on Different Cell Types in Heart Failure
Chengchen Hu1, Jamie Francisco1, Dominic P Del Re1
1Department of Cell Biology and Molecular Medicine, Rutgers New Jersey Medical School.
Summary
The Hippo pathway regulates key cell types in heart failure (HF). Targeting this pathway offers potential for treating cardiovascular diseases like HF.
Area of Science:
- Molecular Biology
- Cardiovascular Research
- Cell Biology
Background:
- The Hippo pathway is crucial for biological regulation.
- Heart failure (HF) presents a significant global health challenge.
- Understanding cellular roles in HF is vital for treatment.
Purpose of the Study:
- To review the Hippo pathway's role in heart failure.
- To analyze its regulation of different cardiac cell types.
- To explore therapeutic potential for cardiovascular diseases.
Main Methods:
- Systematic analysis of Hippo pathway components.
- Review of in vitro and in vivo studies.
- Examination of cellular responses to cardiac injury.
Main Results:
- The Hippo pathway impacts cardiomyocytes, fibroblasts, endothelial cells, and macrophages in HF.
- Specific regulatory mechanisms are elucidated for each cell type.
- Evidence supports the pathway's involvement in cardiac injury response.
Conclusions:
- The Hippo pathway is a key regulator in heart failure.
- Targeting the Hippo pathway shows therapeutic promise for HF.
- Further research can advance treatments for cardiovascular diseases.
Related Concept Videos
Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
422
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
422

